February 2007 Oncology News International

News
Article

Cover Story

  • Pancreatic Ca Vaccine Extends Survival After Surgery

Focus on Lung Cancer

  • BB-10901 Compound Delivers Potent Agent to CD56+ Tumors
  • First-line Nab-paclitaxel Shows Efficacy in NSCLC Trials

Focus on Hematology

  • High Response Rate for Lenalidomide Plus Melphalan and Prednisone in Newly Diagnosed Multiple Myeloma Patients

Cancer Care & Economics

  • Billing Plans for Routine Care Essential When Patients Enroll in Clinical Trials
  • RHIOs Allow Exchange of Electronic Info

Recent Videos
Retrospective and real-world registry studies may be necessary to guide clinical decision-making for rarer lymphomas with insufficient prospective data.
Extravasation results in exposing healthy tissue to radiation, which can be highly dosed depending on the isotope used for treatment.
4 experts in this video
2 experts in this video
2 experts in this video
4 experts in this video
Ongoing studies seek to evaluate immunotherapy in earlier lines of therapy for patients with early-stage Hodgkin lymphoma.
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
Related Content